Cargando…

Validation of an algorithm for identifying MS cases in administrative health claims datasets

OBJECTIVE: To develop a valid algorithm for identifying multiple sclerosis (MS) cases in administrative health claims (AHC) datasets. METHODS: We used 4 AHC datasets from the Veterans Administration (VA), Kaiser Permanente Southern California (KPSC), Manitoba (Canada), and Saskatchewan (Canada). In...

Descripción completa

Detalles Bibliográficos
Autores principales:	Culpepper, William J., Marrie, Ruth Ann, Langer-Gould, Annette, Wallin, Mitchell T., Campbell, Jonathan D., Nelson, Lorene M., Kaye, Wendy E., Wagner, Laurie, Tremlett, Helen, Chen, Lie H., Leung, Stella, Evans, Charity, Yao, Shenzhen, LaRocca, Nicholas G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442008/ https://www.ncbi.nlm.nih.gov/pubmed/30770432 http://dx.doi.org/10.1212/WNL.0000000000007043

Ejemplares similares

The prevalence of MS in the United States: A population-based estimate using health claims data
por: Wallin, Mitchell T., et al.
Publicado: (2019)

A new way to estimate neurologic disease prevalence in the United States: Illustrated with MS
por: Nelson, Lorene M., et al.
Publicado: (2019)

Population-Based Estimates for the Prevalence of Multiple Sclerosis in the United States by Race, Ethnicity, Age, Sex, and Geographic Region
por: Hittle, Michael, et al.
Publicado: (2023)

Medication adherence in multiple sclerosis as a potential model for other chronic diseases: a population-based cohort study
por: Evans, Charity, et al.
Publicado: (2021)

Differences in the burden of psychiatric comorbidity in MS vs the general population
por: Marrie, Ruth Ann, et al.
Publicado: (2015)

Disease-Modifying Drugs for Multiple Sclerosis and Association With Survival
por: Ng, Huah Shin, et al.
Publicado: (2022)

Disease-modifying drugs for multiple sclerosis and subsequent health service use
por: Ng, Huah Shin, et al.
Publicado: (2021)

Emergency department use by persons with MS: A population-based descriptive study with a focus on infection-related visits
por: Graf, Jonas, et al.
Publicado: (2022)

Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition
por: Walton, Clare, et al.
Publicado: (2020)

Differing trends in the incidence of vascular comorbidity in MS and the general population
por: Marrie, Ruth Ann, et al.
Publicado: (2016)

Disease-Modifying Drug Uptake and Health Service Use in the Ageing MS Population
por: Ng, Huah Shin, et al.
Publicado: (2022)

Rituximab, MS, and pregnancy
por: Smith, Jessica B., et al.
Publicado: (2020)

Determinants of non-adherence to disease-modifying therapies in multiple sclerosis: A cross-Canada prospective study
por: McKay, Kyla A, et al.
Publicado: (2016)

Evaluating the safety of β-interferons in MS: A series of nested case-control studies
por: de Jong, Hilda J.I., et al.
Publicado: (2017)

Effect of adherence to the first-generation injectable immunomodulatory drugs on disability accumulation in multiple sclerosis: a longitudinal cohort study
por: Zhang, Tingting, et al.
Publicado: (2017)

Repetitive elements as a transcriptomic marker of aging: Evidence in multiple datasets and models
por: LaRocca, Thomas J., et al.
Publicado: (2020)

Environmental and genetic risk factors for MS: an integrated review
por: Waubant, Emmanuelle, et al.
Publicado: (2019)

Mental comorbidity and multiple sclerosis: validating administrative data to support population-based surveillance
por: Marrie, Ruth Ann, et al.
Publicado: (2013)

Examining the effects of comorbidities on disease-modifying therapy use in multiple sclerosis
por: Zhang, Tingting, et al.
Publicado: (2016)

Defining Benign/Burnt-Out MS and Discontinuing Disease-Modifying Therapies
por: McFaul, Derek, et al.
Publicado: (2021)

Racial and Ethnic Disparities in Multiple Sclerosis Prevalence
por: Langer-Gould, Annette M., et al.
Publicado: (2022)

MS Sunshine Study: Sun Exposure But Not Vitamin D Is Associated with Multiple Sclerosis Risk in Blacks and Hispanics
por: Langer-Gould, Annette, et al.
Publicado: (2018)

Peripartum depression in parents with multiple sclerosis and psychiatric disorders in children
por: Razaz, Neda, et al.
Publicado: (2016)

Disease activity in pregnancy and postpartum in women with MS who suspended rituximab and natalizumab
por: Razaz, Neda, et al.
Publicado: (2020)

Multiple sclerosis disease-modifying drug use by immigrants: a real-world study
por: Graf, Jonas, et al.
Publicado: (2023)

The Impact of Age and Sex Concordance Between Patients and Physicians on Medication Adherence: A Population-Based Study
por: Yao, Shenzhen, et al.
Publicado: (2022)

An integrated continuity of care measure improves performance in models predicting medication adherence using population-based administrative data
por: Yao, Shenzhen, et al.
Publicado: (2022)

Global Status and Trends in Intellectual Property Claims: Patent Dataset for Biodiversity
por: Oldham, Paul, et al.
Publicado: (2006)

Monoclonal antibody treatment during pregnancy and/or lactation in women with MS or neuromyelitis optica spectrum disorder
por: Ciplea, Andrea Ines, et al.
Publicado: (2020)

Oral Contraceptives and Multiple Sclerosis/Clinically Isolated Syndrome Susceptibility
por: Hellwig, Kerstin, et al.
Publicado: (2016)

Children and adolescents adjustment to parental multiple sclerosis: a systematic review
por: Razaz, Neda, et al.
Publicado: (2014)

Editorial Response to Drs. Simone and Mancusi
por: Langer-Gould, Annette
Publicado: (2020)

Serum neurofilament light chain in relapsing-remitting MS: Unchaining disease activity prediction?
por: Marrie, Ruth Ann
Publicado: (2017)

Dataset of mouse hippocampus profiled by LC–MS/MS for label-free quantitation
por: English, Jane A., et al.
Publicado: (2016)

Proteome dataset of Hemileia vastatrix by LC–MS/MS label-free identification
por: Cury, Natália Faustino, et al.
Publicado: (2022)

Physician influence on medication adherence, evidence from a population-based cohort
por: Yao, Shenzhen, et al.
Publicado: (2022)

Sex and age differences in the Multiple Sclerosis prodrome
por: Yusuf, Fardowsa L. A., et al.
Publicado: (2022)

Representing Physician Suicide Claims as Nanopublications: Proof-of-Concept Study Creating Claim Networks
por: Leung, Tiffany I, et al.
Publicado: (2022)

A population-based study comparing multiple sclerosis clinic users and non-users in British Columbia, Canada
por: McKay, Kyla, et al.
Publicado: (2017)

Deep neural network models for identifying incident dementia using claims and EHR datasets
por: Nori, Vijay S., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_us2udobb301el28vom8fpsdqdb